HLTH 2026: Potential 2028 US presidential contender Mark Kelly warns pharma over profits
Following the US midterm elections, Arizona Senator Mark Kelly used day one of HLTH 2026 in Las Vegas to set …
Following the US midterm elections, Arizona Senator Mark Kelly used day one of HLTH 2026 in Las Vegas to set …
On 9 November, at the American Heart Association (AHA) Scientific Sessions 2026 in Chicago, Biykem Bozkurt of Baylor College of …
This year at the American Heart Association (AHA) Scientific Sessions, findings from a nationwide Norwegian study assessing cardiovascular outcomes among …
In recent years, the European biotechnology sector has been thrust into a period of notable change, with new technologies and …
The US Food and Drug Administration (FDA) appears to have quietly paused the Commissioner’s National Priority Voucher (CNPV) pilot programme, …
Swiss biotech company Neurosterix has banked $105m in a Series B funding round to push its range of neuropsychiatric candidates …
Bristol Myers Squibb (BMS) is set to merge its separate research and development (R&D) departments into a single entity, effective …
Japanese pharma major Takeda has commercially launched Orzeyful (oveporexton) in the US for the treatment for adult patients with narcolepsy …
Eli Lilly has beaten its staunch obesity rival Novo Nordisk to market in China by securing an approval for its …
With an eye on entering the obesity market dominated by Eli Lilly, Pfizer has secured $1.5bn from Blackstone Life Sciences …
In recent years, the emergence of the incretin drug class has revolutionised the cardiometabolic treatment space, as doctors increasingly prescribe …
With the curtains closing on another year at BIO-Europe, the attending editorial team is still revelling in the interesting conversations …
The European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) have granted paediatric clinical trial waivers to …
Excitement in the longevity space over peptides comes with the caveat that many claims about their life-extending potential are incomplete …
Life sciences consulting firms Litmys and PharmaACE have formed a strategic collaboration to provide commercial forecasting and decision-making services to …